Search Results Search Sort by RelevanceMost Recent In the Literature Jun 2006 Patent (and Public Health) Pending Philip A. Perry, MSJ The government is justified in using eminent domain to purchase patents in order to produce large amounts of medication during a public health crisis. Virtual Mentor. 2006;8(6):387-391. doi: 10.1001/virtualmentor.2006.8.6.jdsc1-0606. Policy Forum Jan 2006 What Good Is Hypertension Screening If You Don't Do Anything About It? Christian J. Krautkramer The wide gap between hypertension screening and access to treatment for the uninsured needs to be addressed by clinical policymakers. Virtual Mentor. 2006;8(1):42-47. doi: 10.1001/virtualmentor.2006.8.1.pfor1-0601. Case and Commentary Mar 2006 The Pitfalls of Drug Company Sample Use Robert Goodman, MD A physicians urges practitioners to use cost-effective alternatives to dispensing samples to patients who cannot afford to pay for their prescriptions. Virtual Mentor. 2006;8(3):138-141. doi: 10.1001/virtualmentor.2006.8.3.ccas3-0603. Medicine and Society Feb 2006 Bioethics Consultation for Pharmaceutical Corporations Lisa M. Rasmussen, PhD Some bioethicists believe that consulting for pharmaceutical companies is an unethical activity for members of their profession. Virtual Mentor. 2006;8(2):105-108. doi: 10.1001/virtualmentor.2006.8.2.msoc1-0602. Case and Commentary May 2006 Stigmatized Patients' Right to Equal Treatment Kelly D. Brownell, PhD and Rebecca M. Puhl, PhD Physicians should practice bias-reduction strategies in their treatment plans for and attitudes toward overweight and obese patients. Virtual Mentor. 2006;8(5):298-302. doi: 10.1001/virtualmentor.2006.8.5.ccas1-0605. Pagination First page « First Previous page ‹ Previous … Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Current page 11
In the Literature Jun 2006 Patent (and Public Health) Pending Philip A. Perry, MSJ The government is justified in using eminent domain to purchase patents in order to produce large amounts of medication during a public health crisis. Virtual Mentor. 2006;8(6):387-391. doi: 10.1001/virtualmentor.2006.8.6.jdsc1-0606.
Policy Forum Jan 2006 What Good Is Hypertension Screening If You Don't Do Anything About It? Christian J. Krautkramer The wide gap between hypertension screening and access to treatment for the uninsured needs to be addressed by clinical policymakers. Virtual Mentor. 2006;8(1):42-47. doi: 10.1001/virtualmentor.2006.8.1.pfor1-0601.
Case and Commentary Mar 2006 The Pitfalls of Drug Company Sample Use Robert Goodman, MD A physicians urges practitioners to use cost-effective alternatives to dispensing samples to patients who cannot afford to pay for their prescriptions. Virtual Mentor. 2006;8(3):138-141. doi: 10.1001/virtualmentor.2006.8.3.ccas3-0603.
Medicine and Society Feb 2006 Bioethics Consultation for Pharmaceutical Corporations Lisa M. Rasmussen, PhD Some bioethicists believe that consulting for pharmaceutical companies is an unethical activity for members of their profession. Virtual Mentor. 2006;8(2):105-108. doi: 10.1001/virtualmentor.2006.8.2.msoc1-0602.
Case and Commentary May 2006 Stigmatized Patients' Right to Equal Treatment Kelly D. Brownell, PhD and Rebecca M. Puhl, PhD Physicians should practice bias-reduction strategies in their treatment plans for and attitudes toward overweight and obese patients. Virtual Mentor. 2006;8(5):298-302. doi: 10.1001/virtualmentor.2006.8.5.ccas1-0605.